GENELUX Corp

Ownership Transactions Reported by 18 Insiders

Symbol
GNLX on Nasdaq
Industry
Pharmaceutical Preparations
Location
2625 Townsgate Road, Suite 230, Westlake Village, CA

Insiders trading volume in the past year

GENELUX Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Qian Zhang Associate VP, Research $1.98M Feb 17, 2023
Thomas Zindrick President and CEO, Director $1.86M -$64.9K -3.37% Sep 1, 2025
John Thomas Director $1.69M Aug 27, 2025
Aladar Szalay 10%+ Owner $1.55M Sep 12, 2024
Joseph Cappello Chief Technical Officer $537K -$28.6K -5.05% Sep 1, 2025
Yong Yu SVP, Clinical Development $504K -$16.3K -3.13% Sep 1, 2025
John W. Smither Director $252K Aug 27, 2025
Mary Mirabelli Director $246K Aug 27, 2025
Ralph Smalling Head of Regulatory $239K -$9.55K -3.85% Sep 1, 2025
James L. Tyree Director $229K -$8.51K -3.59% Aug 27, 2025
Lourie S. Zak Chief Financial Officer $193K -$4.92K -2.49% Dec 18, 2024
Gabe Woodward Director $175K Feb 17, 2023
Sean Ryder General Counsel $139K -$13.1K -8.59% May 12, 2025
Caroline Jewett Head of Quality $34.3K Feb 19, 2024
Doug Samuelson Vice President, Finance $32.6K Sep 11, 2023
Paul Scigalla Chief Medical Officer Oct 18, 2024
Eric Groen General Counsel & Secretary Jul 1, 2025
Matthew Pulisic Chief Financial Officer Jan 31, 2025

Recent Insider Transactions by Companies or Individuals for GENELUX Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.